IBIO, INC. Research and Development Expense
IBIO, INC. (IBIO) reported Research and Development Expense of $19.64 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-28
- IBIO, INC. research and development expense for the quarter ending 2026-06-30 was $8.56M, a 165.48% increase year-over-year.
- IBIO, INC. research and development expense for the quarter ending 2026-03-31 was $3.25M, a 70.72% increase year-over-year.
- IBIO, INC. research and development expense for the quarter ending 2025-12-31 was $4.28M, a 128.02% increase year-over-year.
- IBIO, INC. research and development expense for the quarter ending 2025-09-30 was $3.55M, a 172.03% increase year-over-year.
- IBIO, INC. research and development expense for fiscal 2026 was $19.64M, a 136.32% increase from fiscal 2025.
- IBIO, INC. research and development expense for fiscal 2025 was $8.31M, a 60.31% increase from fiscal 2024.
- IBIO, INC. research and development expense for fiscal 2024 was $5.18M, a 49.79% decline from fiscal 2023.
- IBIO, INC. research and development expense for fiscal 2023 was $10.33M, a 5.09% increase from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | $11.81M derived: sum of 2 quarters · filed 2026-08-28 | $16.09M derived: sum of 3 quarters · filed 2026-08-28 | $19.64M 10-K · filed 2026-08-28 | ||||
| 2026-03-31 | $3.25M 10-Q · filed 2026-05-12 | $7.53M derived: sum of 2 quarters · filed 2026-05-12 | $11.08M 10-Q · filed 2026-05-12 | $14.31M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | $4.28M 10-Q · filed 2026-02-10 | $7.83M 10-Q · filed 2026-02-10 | $11.05M derived: sum of 3 quarters · filed 2026-08-28 | $12.96M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | $3.55M 10-Q/A · filed 2025-11-17 | $6.77M derived: sum of 2 quarters · filed 2026-08-28 | $8.68M derived: sum of 3 quarters · filed 2026-08-28 | $10.56M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-06-30 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | $5.13M derived: sum of 2 quarters · filed 2026-08-28 | $7.01M derived: sum of 3 quarters · filed 2026-08-28 | $8.31M 10-K · filed 2026-08-28 | ||||
| 2025-03-31 | $1.91M 10-Q · filed 2026-05-12 | $3.78M derived: sum of 2 quarters · filed 2026-05-12 | $5.09M 10-Q · filed 2026-05-12 | $6.23M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $1.88M 10-Q · filed 2026-02-10 | $3.18M 10-Q · filed 2026-02-10 | $4.32M derived: sum of 3 quarters · filed 2026-02-10 | $5.23M derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-09-30 | $1.30M 10-Q/A · filed 2025-11-17 | $2.44M derived: sum of 2 quarters · filed 2025-11-17 | $3.35M derived: sum of 3 quarters · filed 2025-11-17 | $4.88M derived: sum of 4 quarters · filed 2025-11-17 | ||||
| 2024-06-30 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-05 | $2.04M derived: sum of 2 quarters · filed 2025-09-05 | $3.58M derived: sum of 3 quarters · filed 2025-09-05 | $5.18M 10-K · filed 2025-09-05 | ||||
| 2024-03-31 | $904.00K 10-Q · filed 2025-05-02 | $2.44M derived: sum of 2 quarters · filed 2025-05-02 | $4.04M 10-Q · filed 2025-05-02 | $6.40M derived: sum of 4 quarters · filed 2025-05-02 | ||||
| 2023-12-31 | $1.53M 10-Q · filed 2025-02-10 | $3.14M 10-Q · filed 2025-02-10 | $5.50M derived: sum of 3 quarters · filed 2025-02-10 | $8.14M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-09-30 | $1.61M 10-Q · filed 2024-11-12 | $3.96M derived: sum of 2 quarters · filed 2024-11-12 | $6.61M derived: sum of 3 quarters · filed 2024-11-12 | $9.38M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $2.36M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-24 | $5.00M derived: sum of 2 quarters · filed 2024-09-24 | $7.78M derived: sum of 3 quarters · filed 2024-09-24 | $10.33M 10-K/A · filed 2024-09-24 | ||||
| 2023-03-31 | $2.64M 10-Q · filed 2024-05-13 | $5.42M derived: sum of 2 quarters · filed 2024-05-13 | $7.97M 10-Q · filed 2024-05-13 | $11.53M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $2.78M 10-Q · filed 2024-02-09 | $5.33M 10-Q · filed 2024-02-09 | $8.89M derived: sum of 3 quarters · filed 2024-02-09 | $12.16M derived: sum of 4 quarters · filed 2024-02-09 | ||||
| 2022-09-30 | $2.55M 10-Q · filed 2023-11-14 | $6.11M derived: sum of 2 quarters · filed 2023-11-14 | $9.38M derived: sum of 3 quarters · filed 2023-11-14 | $11.24M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-27 | $6.83M derived: sum of 2 quarters · filed 2023-09-27 | $8.69M derived: sum of 3 quarters · filed 2023-09-27 | $9.83M 10-K · filed 2023-09-27 | $17.73M 10-K · filed 2022-10-11 | |||
| 2022-03-31 | $3.27M 10-Q · filed 2023-05-15 | $5.55M 10-Q · filed 2022-05-12 | $5.13M derived: sum of 2 quarters · filed 2023-05-19 | $6.26M 10-Q · filed 2023-05-15 | $11.39M 10-Q · filed 2022-05-12 | $9.36M derived: sum of 4 quarters · filed 2023-05-19 | ||
| 2021-12-31 | $1.86M 10-Q/A · filed 2023-05-19 | $3.33M 10-Q · filed 2022-02-14 | $2.99M 10-Q/A · filed 2023-05-19 | $5.84M 10-Q · filed 2022-02-14 | $6.09M derived: sum of 3 quarters · filed 2023-05-19 | $8.25M derived: sum of 4 quarters · filed 2023-05-19 | ||
| 2021-09-30 | $1.13M 10-Q · filed 2022-11-14 | $2.51M 10-Q · filed 2021-11-15 | $4.23M derived: sum of 2 quarters · filed 2022-11-14 | $6.39M derived: sum of 3 quarters · filed 2022-11-14 | $8.77M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-11 | $5.26M derived: sum of 2 quarters · filed 2022-10-11 | $7.63M derived: sum of 3 quarters · filed 2022-10-11 | $9.99M 10-K · filed 2022-10-11 | ||||
| 2021-03-31 | $2.16M 10-Q · filed 2022-05-12 | $4.54M derived: sum of 2 quarters · filed 2022-05-12 | $6.89M 10-Q · filed 2022-05-12 | $6.98M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $2.37M 10-Q · filed 2022-02-14 | $2.44M 10-Q · filed 2021-02-16 | $4.24M 10-Q · filed 2022-02-14 | $4.21M 10-Q · filed 2021-02-16 | $4.82M derived: sum of 3 quarters · filed 2022-02-14 | $5.91M derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2020-09-30 | $1.86M 10-Q · filed 2021-11-15 | $1.76M 10-Q · filed 2020-11-16 | $2.44M derived: sum of 2 quarters · filed 2021-11-15 | $3.54M derived: sum of 3 quarters · filed 2021-11-15 | $4.43M derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $1.68M derived: sum of 2 quarters · filed 2021-09-28 | $2.57M derived: sum of 3 quarters · filed 2021-09-28 | $3.57M 10-K · filed 2021-09-28 | $3.21M 10-K · filed 2020-10-13 | |||
| 2020-03-31 | $1.09M 10-Q · filed 2021-05-17 | $999.00K 10-Q · filed 2020-05-15 | $1.98M derived: sum of 2 quarters · filed 2021-05-17 | $2.99M 10-Q · filed 2021-05-17 | $2.86M 10-Q · filed 2020-05-15 | $4.58M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $888.00K 10-Q · filed 2021-02-16 | $1.86M 10-Q · filed 2021-02-16 | $3.49M derived: sum of 3 quarters · filed 2021-02-16 | $4.94M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | $977.00K 10-Q · filed 2020-11-16 | $2.60M derived: sum of 2 quarters · filed 2020-11-16 | $4.05M derived: sum of 3 quarters · filed 2020-11-16 | $5.33M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $3.08M derived: sum of 2 quarters · filed 2020-10-13 | $4.35M derived: sum of 3 quarters · filed 2020-10-13 | $5.47M 10-K · filed 2020-10-13 | ||||
| 2019-03-31 | $1.45M 10-Q · filed 2020-05-15 | $2.73M derived: sum of 2 quarters · filed 2020-05-15 | $3.85M 10-Q · filed 2020-05-15 | $4.89M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $1.27M 10-Q · filed 2020-02-14 | $2.40M 10-Q · filed 2020-02-14 | $3.44M derived: sum of 3 quarters · filed 2020-02-14 | $4.41M derived: sum of 4 quarters · filed 2020-02-14 | ||||
| 2018-09-30 | $1.12M 10-Q · filed 2019-11-14 | $2.17M derived: sum of 2 quarters · filed 2019-11-14 | $3.13M derived: sum of 3 quarters · filed 2019-11-14 | $4.13M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26 | $2.01M derived: sum of 2 quarters · filed 2019-08-26 | $3.00M derived: sum of 3 quarters · filed 2019-08-26 | $3.99M 10-K · filed 2019-08-26 | ||||
| 2018-03-31 | $966.00K 10-Q · filed 2019-05-10 | $1.96M derived: sum of 2 quarters · filed 2019-05-10 | $2.94M 10-Q · filed 2019-05-10 | $4.06M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $993.00K 10-Q · filed 2019-02-13 | $1.98M 10-Q · filed 2019-02-13 | $3.09M derived: sum of 3 quarters · filed 2019-02-13 | $4.23M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-09-30 | $985.00K 10-Q · filed 2018-11-13 | $2.10M derived: sum of 2 quarters · filed 2018-11-13 | $3.23M derived: sum of 3 quarters · filed 2018-11-13 | $4.28M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-18 | $2.25M derived: sum of 2 quarters · filed 2018-09-18 | $3.30M derived: sum of 3 quarters · filed 2018-09-18 | $4.12M 10-K · filed 2018-09-18 | ||||
| 2017-03-31 | $1.14M 10-Q · filed 2018-05-11 | $2.19M derived: sum of 2 quarters · filed 2018-05-11 | $3.00M 10-Q · filed 2018-05-11 | $3.86M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $1.05M 10-Q · filed 2018-02-14 | $1.87M 10-Q · filed 2018-02-14 | $2.72M derived: sum of 3 quarters · filed 2018-02-14 | $3.77M derived: sum of 4 quarters · filed 2018-02-14 | ||||
| 2016-09-30 | $820.00K 10-Q · filed 2017-11-09 | $1.67M derived: sum of 2 quarters · filed 2017-11-09 | $2.72M derived: sum of 3 quarters · filed 2017-11-09 | $3.42M derived: sum of 4 quarters · filed 2017-11-09 | ||||
| 2016-06-30 | $853.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-15 | $1.90M derived: sum of 2 quarters · filed 2017-09-15 | $2.60M derived: sum of 3 quarters · filed 2017-09-15 | $3.16M 10-K · filed 2017-09-15 | ||||
| 2016-03-31 | $1.05M 10-Q · filed 2017-05-15 | $1.75M derived: sum of 2 quarters · filed 2017-05-15 | $2.30M 10-Q · filed 2017-05-15 | $3.07M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $704.00K 10-Q · filed 2017-02-21 | $1.25M 10-Q · filed 2017-02-21 | $2.02M derived: sum of 3 quarters · filed 2017-02-21 | $2.83M derived: sum of 4 quarters · filed 2017-02-21 | ||||
| 2015-09-30 | $551.00K 10-Q · filed 2016-11-18 | $1.31M derived: sum of 2 quarters · filed 2016-11-18 | $2.13M derived: sum of 3 quarters · filed 2016-11-18 | $2.86M derived: sum of 4 quarters · filed 2016-11-18 | ||||
| 2015-06-30 | $764.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | $1.58M derived: sum of 2 quarters · filed 2016-10-13 | $2.31M derived: sum of 3 quarters · filed 2016-10-13 | $3.50M 10-K · filed 2016-10-13 | ||||
| 2015-03-31 | $815.00K 10-Q · filed 2016-05-23 | $1.55M derived: sum of 2 quarters · filed 2016-05-23 | $2.73M 10-Q · filed 2016-05-23 | $3.15M derived: sum of 4 quarters · filed 2016-05-23 | ||||
| 2014-12-31 | $731.00K 10-Q · filed 2016-02-22 | $1.92M 10-Q · filed 2016-02-22 | $2.33M derived: sum of 3 quarters · filed 2016-02-22 | $2.68M derived: sum of 4 quarters · filed 2016-02-22 | ||||
| 2014-09-30 | $1.19M 10-Q · filed 2015-11-13 | $1.60M derived: sum of 2 quarters · filed 2015-11-13 | $1.95M derived: sum of 3 quarters · filed 2015-11-13 | $2.53M derived: sum of 4 quarters · filed 2015-11-13 | ||||
| 2014-06-30 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-13 | $761.00K derived: sum of 2 quarters · filed 2015-10-13 | $1.35M derived: sum of 3 quarters · filed 2015-10-13 | $1.90M 10-K · filed 2015-10-13 | ||||
| 2014-03-31 | $343.00K 10-Q · filed 2015-05-15 | $928.00K derived: sum of 2 quarters · filed 2015-05-15 | $1.48M 10-Q · filed 2015-05-15 | $2.45M derived: sum of 4 quarters · filed 2015-05-15 | ||||
| 2013-12-31 | $585.00K 10-Q · filed 2015-02-24 | $1.14M 10-Q · filed 2015-02-24 | $2.10M derived: sum of 3 quarters · filed 2015-02-24 | $2.73M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-09-30 | $552.00K 10-Q · filed 2014-11-14 | $1.52M derived: sum of 2 quarters · filed 2014-11-14 | $2.15M derived: sum of 3 quarters · filed 2014-11-14 | $2.81M derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | $967.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | $1.60M derived: sum of 2 quarters · filed 2014-09-29 | $2.25M derived: sum of 3 quarters · filed 2014-09-29 | $3.43M 10-K · filed 2014-09-29 | ||||
| 2013-03-31 | $631.00K 10-Q · filed 2014-05-15 | $631.19K 10-Q · filed 2013-05-20 | $1.29M derived: sum of 2 quarters · filed 2014-05-15 | $2.46M 10-Q · filed 2014-05-15 | $2.46M 10-Q · filed 2013-05-20 | $3.52M derived: sum of 4 quarters · filed 2014-05-15 | ||
| 2012-12-31 | $656.00K 10-Q · filed 2014-02-14 | $655.78K 10-Q · filed 2013-02-19 | $1.83M 10-Q · filed 2014-02-14 | $1.83M 10-Q · filed 2013-02-19 | $2.89M derived: sum of 3 quarters · filed 2014-02-14 | $4.20M derived: sum of 4 quarters · filed 2014-02-14 | ||
| 2012-09-30 | $1.18M 10-Q · filed 2013-11-14 | $1.18M 10-Q · filed 2012-11-14 | $2.23M derived: sum of 2 quarters · filed 2013-11-14 | $3.54M derived: sum of 3 quarters · filed 2013-11-14 | $4.70M derived: sum of 4 quarters · filed 2013-11-14 | |||
| 2012-06-30 | $1.05M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-10-04 | $2.36M derived: sum of 2 quarters · filed 2013-10-04 | $3.52M derived: sum of 3 quarters · filed 2013-10-04 | $4.98M 10-K/A · filed 2013-10-04 | $4.98M 10-K/A · filed 2012-10-15 | |||
| 2012-03-31 | $1.31M 10-Q · filed 2013-05-20 | $2.47M derived: sum of 2 quarters · filed 2013-05-20 | $3.93M 10-Q · filed 2013-05-20 | $5.10M derived: sum of 4 quarters · filed 2013-05-20 | ||||
| 2011-12-31 | $1.16M 10-Q · filed 2013-02-19 | $2.62M 10-Q · filed 2013-02-19 | $3.79M derived: sum of 3 quarters · filed 2013-02-19 | $4.93M derived: sum of 4 quarters · filed 2013-02-19 | ||||
| 2011-09-30 | $1.46M 10-Q · filed 2012-11-14 | $2.63M derived: sum of 2 quarters · filed 2012-11-14 | $3.76M derived: sum of 3 quarters · filed 2012-11-14 | $4.38M derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | $1.17M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-15 | $2.31M derived: sum of 2 quarters · filed 2012-10-15 | $2.93M derived: sum of 3 quarters · filed 2012-10-15 | $3.08M 10-K/A · filed 2012-10-15 | ||||
| 2011-03-31 | $1.14M 10-Q · filed 2012-05-15 | $1.76M derived: sum of 2 quarters · filed 2012-05-15 | $1.91M 10-Q · filed 2012-05-15 | |||||
| 2010-12-31 | $619.54K 10-Q · filed 2012-02-14 | $777.08K 10-Q · filed 2012-02-14 | ||||||
| 2010-09-30 | $157.54K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |